Claims
- 1. A method for treating obesity in a mammal, comprising the step of orally administering to the mammal an effective amount of one or more fat-binding polymers in combination with one or more lipase inhibitors.
- 2 The method of claim 1 wherein the lipase inhibitor is selected from lipstatin, tetrahydrolipstatin or a combination thereof.
- 3. The method of claim 1 wherein the fat-binding polymer comprises a monomer of the formula
- 4. The method of claim 3 herein the hydrophobic region comprises a substituted or unsubstituted, normal, branched or cyclic alkyl group having at least about four carbons.
- 5. The method of claim 3 wherein the hydrophobic region comprises an alkyl group of between about four and thirty carbons.
- 6 The method of claim 3 wherein the hydrophobic region comprises an alkyl group of about 6 carbons.
- 7. A method for reducing the absorption of dietary fat in a mammal, comprising the step of orally administering to the mammal a therapeutic amount of one or more fat-binding polymers in combination with one or more lipase inhibitors.
RELATED APPLICATIONS
[0001] This application is a Continuation of U.S. application Ser. No. 09/721,309, filed Nov. 22, 2000, which is a Divisional of U.S. application Ser. No. 09/166,453, filed Oct. 5, 1998, which is a Continuation-in-Part of U.S. application Ser. No. 09/004,963 filed on Jan. 9, 1998, the entire content of which is hereby incorporated by reference.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09166453 |
Oct 1998 |
US |
Child |
09721309 |
Nov 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09721309 |
Nov 2000 |
US |
Child |
10307151 |
Nov 2002 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09004963 |
Jan 1998 |
US |
Child |
09166453 |
Oct 1998 |
US |